Skip to content

H2020HORIZONFP7

Ospedale San Raffaele SRL

Country
ITItaly
Defence projects
0
Projects, all programmes
121
As coordinator
49
EU contribution (CORDIS)
EUR 59,091,116
Active
2008 to 2025

Projects

121 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
EATRIS-PlusConsolidating the capacities of EATRIS-ERIC for Personalised MedicineH20202020Third partyNot stated
PHASTPhotonics for Healthcare: multiscAle cancer diagnosiS and TherapyH20202020ParticipantEUR 261,500
SCilSStudying Ciliary Signaling in Development and DiseaseH20202020ParticipantEUR 261,500
ESPACEHuman Cell Atlas of the PancreasH20202020ParticipantEUR 295,750
AXONENDOEndosomal control of local protein synthesis in axonsH20202020CoordinatorEUR 1,499,563
RENergeticCommunity-empowered Sustainable Multi-Vector Energy IslandsH20202020ParticipantEUR 236,688
2LIVErIL-2 gene therapy for chronic hepatitis B virus infectionH20202020CoordinatorEUR 150,000
FF2020Creating the 21st century spatial ecosystemH20202020ParticipantEUR 338,750
INsTRuCTINnovative Training in Myeloid Regulatory Cell TherapyH20202020ParticipantEUR 261,500
SoMuKTSOmatic MUtagenesis in Kidney Tubule is enhanced by specific metabolic pathwaysH20202020CoordinatorEUR 183,473
IDEALInhibitor of DUX4-IGH to Erase Acute lymphoblastic LeukaemiaH20202020CoordinatorEUR 171,473
B1MGBeyond 1M GenomesH20202020Third partyNot stated
DADA2GTDevelopment of gene therapy and genome editing strategies to treat adenosine deaminase 2 deficiencyH20202019CoordinatorEUR 183,473
BrainCircuit-on-chipMicrofluidic chambers for establishing physiological and pathological human iPSC-derived neuronal circuitsH20202019CoordinatorEUR 100,000
HI_IM_NEUROSOCIETYHIstory and IMpact of NEUROimaging on SOCIETYH20202019CoordinatorEUR 168,277
LEUKEYOLKUncovering the origin and mechanisms of Down syndrome-associated leukaemia through human induced pluripotent stem cell-derived haemopoiesisH20202019CoordinatorEUR 168,277
Phys2BioMedBiomechanics in health and disease: advanced physical tools for innovative early diagnosisH20202019ParticipantEUR 261,500
UPGRADEUnlocking Precision Gene TherapyH20202019Third partyNot stated
RTTOPHAGYInvestigating autophagy enhancement as a therapeutic approach for the treatment of Rett syndrome.H20202019CoordinatorEUR 171,473
ImmunoStemDissecting and Overcoming Innate Immune Barriers for Therapeutically Efficient Hematopoietic Stem Cell Gene EngineeringH20202019ParticipantEUR 1,394,375

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.